Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse model

Phytotherapy Research

Volumn 28, Issue 6, 2014, Pages 892-898

  Wen, Xiao Dong ^a,b,c   Wang, Chong Zhi ^a,b   Yu, Chunhao ^a,b   Zhao, Lei ^b   Zhang, Zhiyu ^a,b   Matin, Adiba ^a,b   Wang, Yunwei ^b   Li, Ping ^c   Xiao, Shu Yuan ^b   Du, Wei ^d   He, Tong Chuan ^b   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

AOM DSS model; colitis; colorectal carcinogenesis; inflammatory bowel disease; notoginseng; Panax notoginseng

Indexed keywords

CYCLOOXYGENASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; PANAX NOTOGINSENG EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; COLITIS; COLON LENGTH; CONTROLLED STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; HISTOLOGY; MALE; MOUSE; NONHUMAN; PANAX NOTOGINSENG; PLANT ROOT; PROTEIN EXPRESSION; WEIGHT REDUCTION;

ANIMALIA; MUS; PANAX NOTOGINSENG;

AOM/DSS MODEL; COLITIS; COLORECTAL CARCINOGENESIS; INFLAMMATORY BOWEL DISEASE; NOTOGINSENG; PANAX NOTOGINSENG;

ANIMALS; AZOXYMETHANE; COLITIS; COLON; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; MALE; MICE; NITRIC OXIDE SYNTHASE TYPE II; PANAX NOTOGINSENG; PLANT EXTRACTS; SAPONINS;

EID: 84902282733     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5066     Document Type: Article

References (45)

1. Andersen V, Halfvarson J, Vogel U,. 2012. Colorectal cancer in patients with inflammatory bowel disease: can we predict risk? World J Gastroenterol 18: 4091-4094.
2. Chen FD, Wu MC, Wang HE, et al,. 2001. Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract. Am J Chin Med 29: 517-524.
3. Fiocchi C,. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
4. Garcia Rodriguez LA, Cea-Soriano L, Tacconelli S, Patrignani P,. 2013. Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials. Recent Results Cancer Res 191: 67-93.
5. Geier MS, Butler RN, Howarth GS,. 2007. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 115: 1-11.
6. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM,. 2006. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131: 1122-1130.
7. Hanauer SB,. 1996. Inflammatory bowel disease. N Engl J Med 334: 841-848.
8. He NW, Zhao Y, Guo L, Shang J, Yang XB,. 2012. Antioxidant, antiproliferative, and pro-apoptotic activities of a saponin extract derived from the roots of Panax notoginseng (Burk.) F.H. Chen. J Med Food 15: 350-359.
9. Huang W, Yu J, Jia X, Xiong L, Li N, Wen X,. 2012. Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats. Am J Chin Med 40: 721-733.
10. Jin HR, Zhao J, Zhang Z, et al,. 2012. The antitumor natural compound falcarindiol promotes cancer cell death by inducing endoplasmic reticulum stress. Cell Death Dis 3: e376.
11. Jin Y, Hofseth AB, Cui X, et al,. 2010. American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells. Cancer Prev Res 3: 339-347.
12. Kim SJ, Kim KW, Kim DS, et al,. 2011. The protective effect of Cassia obtusifolia on DSS-induced colitis. Am J Chin Med 39: 565-577.
13. Kohn A, Meddi P,. 2012. How to manage IBD in patients with infections or malignancies? Dig Dis 30: 420-424.
14. Kohno H, Suzuki R, Curini M, et al,. 2006. Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 118: 2936-2942.
15. Konoshima T, Takasaki M, Tokuda H,. 1999. Anti-carcinogenic activity of the roots of Panax notoginseng. II. Biol Pharm Bull 22: 1150-1152.
16. Long TM, Chakrabarti A, Ezelle HJ, et al,. 2013. RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer. Inflamm Bowel Dis 19: 1295-1305.
17. Madka V, Rao CV,. 2013. Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets 13: 542-557.
18. Maltzman T, Whittington J, Driggers L, Stephens J, Ahnen D,. 1997. AOM-induced mouse colon tumors do not express full-length APC protein. Carcinogenesis 18: 2435-2439.
19. Mao Q, Yang J, Cui XM, et al,. 2012. Target separation of a new anti-tumor saponin and metabolic profiling of leaves of Panax notoginseng by liquid chromatography with eletrospray ionization quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 59: 67-77.
20. Murthy S,. 2006. Animal models of inflammatory bowel disease. In Vivo Model Inflamm 2: 137-174.
21. Neufert C, Becker C, Neurath MF,. 2007. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2: 1998-2004.
22. Ohnishi R, Matsui-Yuasa I, Deguchi Y, et al,. 2012. 1 -acetoxychavicol acetate inhibits adipogenesis in 3 T3-L1 adipocytes and in high fat-fed rats. Am J Chin Med 40: 1189-1204.
23. Oz HS, Chen T, de Villiers WJ,. 2013. Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Front Immunol 4: e132.
24. Poole AJ, Heap D, Carroll RE, Tyner AL,. 2004. Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 23: 8128-8134.
25. Poudyal D, Le PM, Davis T, et al,. 2012. A hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms. Cancer Prev Res 5: 685-696.
26. Siegel R, Naishadham D, Jemal A,. 2013. Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
27. Sliva D, Loganathan J, Jiang J, et al,. 2012. Mushroom Ganoderma lucidum prevents colitis-associated carcinogenesis in mice. PLoS ONE 7: e47873.
28. Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ, Yuan CS,. 2011. Red notoginseng: higher ginsenoside content and stronger anticancer potential than Asian and American ginseng. Food Chem 125: 1299-1305.
29. Tanaka T,. 2009. Colorectal carcinogenesis: review of human and experimental animal studies. J Carcinog 8: e5.
30. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H,. 2003. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 94: 965-973.
31. Ushiroyama T, Yokoyama N, Hakukawa M, Sakuma K, Ichikawa F, Yoshida S,. 2012. Clinical efficacy of macrophage-activating Chinese mixed herbs (MACH) in improvement of embryo qualities in women with long-term infertility of unknown etiology. Am J Chin Med 40: 1-10.
32. Velmurugan B, Singh RP, Kaul N, Agarwal R, Agarwal C,. 2010. Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APCmin/+ mice. Neoplasia 12: 95-102.
33. Wang CZ, Aung HH, Zhang B, et al,. 2008. Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res 28: 2545-2551.
34. Wang CZ, Calway T, Yuan CS,. 2012a. Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med 40: 657-669.
35. Wang CZ, Luo X, Zhang B, et al,. 2007a. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother Pharmacol 60: 69-79.
36. Wang CZ, McEntee E, Wicks S, Wu JA, Yuan CS,. 2006. Phytochemical and analytical studies of Panax notoginseng (Burk.) F.H. Chen. J Nat Med 60: 97-106.
37. Wang CZ, Ni M, Sun S, et al,. 2009a. Detection of adulteration of notoginseng root extract with other Panax species by quantitative HPLC coupled with PCA. J Agric Food Chem 57: 2363-2367.
38. Wang CZ, Xie JT, Fishbein A, et al,. 2009b. Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells. Phytother Res 23: 6-13.
39. Wang CZ, Xie JT, Zhang B, et al,. 2007b. Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells. Int J Oncol 31: 1149-1156.
40. Wang HY, Qi LW, Wang CZ, Li P,. 2011. Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides. Am J Chin Med 39: 1103-1115.
41. Wang X, Zhang A, Sun H, Wang P,. 2012b. Systems biology technologies enable personalized traditional Chinese medicine: a systematic review. Am J Chin Med 40: 1109-1122.
42. Wen XD, Yang J, Ma RH, et al,. 2012. Analysis of Panax notoginseng metabolites in rat bile by liquid chromatography-quadrupole time-of-flight mass spectrometry with microdialysis sampling. J Chromatogr B 895-896: 162-168.
43. Yamada Y, Mori H,. 2007. Multistep carcinogenesis of the colon in Apc(Min/+) mouse. Cancer Sci 98: 6-10.
44. Yasui Y, Hosokawa M, Mikami N, Miyashita K, Tanaka T,. 2011. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem Biol Interact 193: 79-87.
45. Zhou Y, Boudreau DM, Freedman AN,. 2013. Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf 27: 165-174.